Clinical Trial Update: Prevention of Cognitive Decline in Alzheimer's Disease by Ingested Interferon Alpha [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigates whether ingested interferon-alpha can prevent cognitive decline in individuals with Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Interferon-alpha (interferon alpha)

Snippet

Sponsor: National Center for Research Resources (NCRR) | Conditions: Memory Disorders, Alzheimer's Disease | Phase 2 | Status: UNKNOWN